Clinical Trials Directory

Trials / Sponsors / Cambridge Antibody Technology

Cambridge Antibody Technology

Academic / Other · 3 registered clinical trials.

StatusTrialPhaseStarted
UnknownSafety Study of CAT-8015 Immunoxin in Patients With NHL With Advance Disease
Leukemia, Non-Hodgkin's Lymphoma, NHL
Phase 12007-08-01
UnknownSafety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease
Leukemia, Hairy Cell Leukemia, HCL
Phase 12007-04-01
UnknownSafety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease
Leukemia
Phase 12007-03-01